ketanserin and quetiapine fumarate

ketanserin has been researched along with quetiapine fumarate in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aggernaes, B; Baaré, WF; Ebdrup, BH; Erritzoe, D; Glenthoj, B; Kalbitzer, J; Knudsen, GM; Lublin, H; Oranje, B; Pinborg, LH; Rasmussen, H; Svarer, C	1
Ebdrup, BH; Glenthøj, B; Knudsen, GM; Oranje, B; Pinborg, LH; Rasmussen, H	1

Trials

1 trial(s) available for ketanserin and quetiapine fumarate

Article	Year
Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine. Psychopharmacology, 2011, Volume: 213, Issue:2-3 Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Ketanserin; Longitudinal Studies; Male; Positron-Emission Tomography; Quetiapine Fumarate; Receptor, Serotonin, 5-HT2A; Schizophrenia; Schizophrenic Psychology; Time Factors; Young Adult	2011

Article

Year

Serotonin2A receptor blockade and clinical effect in first-episode schizophrenia patients treated with quetiapine.

Psychopharmacology, 2011, Volume: 213, Issue:2-3

Topics: Adult; Antipsychotic Agents; Dibenzothiazepines; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Ketanserin; Longitudinal Studies; Male; Positron-Emission Tomography; Quetiapine Fumarate; Receptor, Serotonin, 5-HT2A; Schizophrenia; Schizophrenic Psychology; Time Factors; Young Adult

2011

Other Studies

1 other study(ies) available for ketanserin and quetiapine fumarate

Article	Year
Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients. The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:11 Topics: Adult; Antipsychotic Agents; Body Mass Index; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Ketanserin; Male; Neocortex; Positron-Emission Tomography; Predictive Value of Tests; Protein Binding; Quetiapine Fumarate; Receptor, Serotonin, 5-HT2A; Schizophrenia; Serotonin Antagonists; Weight Gain; Young Adult	2014

Article

Year

Neocortical serotonin2A receptor binding predicts quetiapine associated weight gain in antipsychotic-naive first-episode schizophrenia patients.

The international journal of neuropsychopharmacology, 2014, Volume: 17, Issue:11

Topics: Adult; Antipsychotic Agents; Body Mass Index; Dibenzothiazepines; Female; Follow-Up Studies; Humans; Imaging, Three-Dimensional; Ketanserin; Male; Neocortex; Positron-Emission Tomography; Predictive Value of Tests; Protein Binding; Quetiapine Fumarate; Receptor, Serotonin, 5-HT2A; Schizophrenia; Serotonin Antagonists; Weight Gain; Young Adult

2014